EMERGING TESTS

Progress Seen With EGFR Testing, But Adoption Still Lagging

Incomplete implementation of EGFR testing guidelines remains a problem in the realm of non-small cell lung cancer (NSCLC), according to a study published in the Journal of Global Oncology. The authors … [Read more...]

PRECISION MEDICINE

Can a Blood Test Quantify Pain?

A new test could help clinicians objectively measure pain. According to a study published Feb. 12 in Molecular Psychiatry, the identified biomarkers can predict pain severity and future emergency … [Read more...]

PRECISION MEDICINE

Exome Sequencing Improves Diagnosis of Fetal Structural Anomalies

Prenatal diagnostics have evolved from conventional cytogenetic analysis to increasingly chromosomal microarray analysis, within the last 10 years. While whole-exome sequencing (WES) has shown utility … [Read more...]

PRECISION MEDICINE

Donor-Derived, Cell-Free DNA May Predict Lung Transplant Rejection

Elevated donor-derived, cell-free DNA (ddcfDNA) in the 3 months post-lung transplant can identify clinically silent allograft injury and predict progression to chronic rejection, according to a … [Read more...]

EMERGING TESTS

Calprotectin May Predict Arthritis Relapse

Baseline calprotectin serum levels independently predicted disease relapse in patients with rheumatoid arthritis (RA) and psoriatic arthritis (PsA) taking tumor necrosis factor inhibitors (TNFi) … [Read more...]

EMERGING TESTS

Study Showing PGx Testing Improves Depression Outcomes, Key to Myriad’s Reimbursement Strategy

Pharmacogenomic testing (PGx) provides clinically meaningful improvement in response and remission rates for difficult-to-treat depression patients over standard of care, according to a study … [Read more...]

INDUSTRY TRENDS

Diagnostics Sector Saw Increased Investment, Exits in 2018

Life science and health care companies had a banner year in 2018, with a record-breaking year for venture capital investment, according to Silicon Valley Bank's Trends in Healthcare Investments and … [Read more...]

EMERGING TESTS

Sequencing Shows Promise in Care of Common Kidney Disease

Exome sequencing can yield a genetic diagnosis in almost 10 percent of patients with chronic kidney disease (CKD), according to a study published Jan. 10 in the New England Journal of Medicine. This … [Read more...]

EMERGING TESTS

Cytokines Could Predict Risk of Side Effects From Immunotherapy

Blood-based cytokine markers may help identify cancer patients at greatest risk of developing side effects from immunotherapy treatment, according to a pilot study published Oct. 31 in the British … [Read more...]

EMERGING TESTS

Polygenic Risk Score Predicts Drug Efficacy with Schizophrenia

A polygenic risk score (PRS) may be able to predict response to antipsychotic drug treatment in patients with their first episode of psychosis from schizophrenia, according to a study published Nov. 5 … [Read more...]


(-00000g2)